YCBD cbdMD Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: YCBD

Price (delayed)

$0.75

Market cap

$7.87M

P/E Ratio

5.36

Dividend/share

N/A

EPS

$0.14

Enterprise value

$5.65M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 16

cbdMD, Inc. is one of the world’s leading, most highly trusted health & wellness CBD companies, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD botanical ...

Highlights
The EPS has soared by 108% since the previous quarter and by 101% year-on-year
The company's debt has shrunk by 64% YoY and by 30% QoQ
cbdMD's gross profit has decreased by 2.9% YoY but it has increased by 2.6% from the previous quarter
The net income has decreased by 14% QoQ
The quick ratio has decreased by 12% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.cbdmd.com

Key stats

What are the main financial stats of YCBD

YCBD stock price

How has the cbdMD stock price performed over time
Intraday
7.13%
1 week
-9.2%
1 month
-12.37%
1 year
-22.31%
YTD
-44.44%
QTD
1.08%

Financial performance

How have cbdMD's revenue and profit performed over time
Revenue
$19.98M
Gross profit
$11.87M
Operating income
-$2.68M
Net income
-$2.66M
Gross margin
59.4%
Net margin
-13.3%
cbdMD's operating income has plunged by 111% YoY and by 13% from the previous quarter
YCBD's operating margin has dropped by 106% year-on-year and by 8% since the previous quarter
The net income has decreased by 14% QoQ
The company's net margin fell by 8% QoQ

Price vs fundamentals

How does YCBD's price correlate with its fundamentals

Growth

What is cbdMD's growth rate over time

Valuation

What is cbdMD stock price valuation
P/E
5.36
P/B
0.85
P/S
0.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.28
The EPS has soared by 108% since the previous quarter and by 101% year-on-year
The stock's P/B is 39% below its last 4 quarters average of 1.3 and 12% below its 5-year quarterly average of 0.9
YCBD's equity is up by 3.1% since the previous quarter
YCBD's P/S is 47% below its 5-year quarterly average of 0.7 and 8% below its last 4 quarters average of 0.4
The revenue has increased by 4.7% from the previous quarter

Efficiency

How efficient is cbdMD business performance
YCBD's ROIC has soared by 83% YoY and by 33% QoQ
The company's return on equity has surged by 82% YoY and by 39% QoQ
The ROA has grown by 21% YoY and by 19% from the previous quarter
The ROS is down by 9% since the previous quarter

Dividends

What is YCBD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for YCBD.

Financial health

How did cbdMD financials performed over time
YCBD's total liabilities has dropped by 71% year-on-year but it is up by 7% since the previous quarter
The total assets has grown by 12% YoY and by 4% from the previous quarter
The company's debt is 96% lower than its equity
The debt to equity has shrunk by 98% YoY and by 43% QoQ
The company's debt has shrunk by 64% YoY and by 30% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.